Literature DB >> 12965114

Increased formic acid excretion and the development of kidney toxicity in rats following chronic dosing with trichloroethanol, a major metabolite of trichloroethylene.

Trevor Green1, Jacky Dow, John Foster.   

Abstract

The chronic toxicity of trichloroethanol, a major metabolite of trichloroethylene, has been assessed in male Fischer rats (60 per group) given trichloroethanol in drinking water at concentrations of 0, 0.5 and 1.0 g/l for 52 weeks. The rats excreted large amounts of formic acid in urine reaching a maximum after 12 weeks ( approximately 65 mg/24 h at 1 g/l) and thereafter declining to reach an apparent steady state at 40 weeks (15-20 mg/24 h). Urine from treated rats was more acidic throughout the study and urinary methylmalonic acid and plasma N-methyltetrahydrofolate concentrations were increased, indicating an acidosis, vitamin B12 deficiency and impaired folate metabolism, respectively. The rats treated with trichloroethanol developed kidney damage over the duration of the study which was characterised by increased urinary NAG activity, protein excretion (from 4 weeks), increased basophilia, protein accumulation and tubular damage (from 12 to 40 weeks), increased cell replication (at week 28) and evidence in some rats of focal proliferation of abnormal tubules at 52 weeks. It was concluded that trichloroethanol, the major metabolite of trichloroethylene, induced nephrotoxicity in rats as a result of formic acid excretion and acidosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12965114     DOI: 10.1016/s0300-483x(03)00206-3

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  8 in total

1.  Re-assessment of the influence of polymorphisms of phase-II metabolic enzymes on renal cell cancer risk of trichloroethylene-exposed workers.

Authors:  Bernd Wiesenhütter; Silvia Selinski; Klaus Golka; Thomas Brüning; Hermann M Bolt
Journal:  Int Arch Occup Environ Health       Date:  2007-05-04       Impact factor: 3.015

2.  The effect of trichloroethylene metabolites on the hepatic vitamin B12-dependent methionine salvage pathway and its relevance to increased excretion of formic acid in the rat.

Authors:  Noreen Yaqoob; Katarzyna M Bloch; Andrew R Evans; Edward A Lock
Journal:  Toxicol Res (Camb)       Date:  2020-04-24       Impact factor: 3.524

3.  Comparative analysis of metabolism of trichloroethylene and tetrachloroethylene among mouse tissues and strains.

Authors:  Yu-Syuan Luo; Nan-Hung Hsieh; Valerie Y Soldatow; Weihsueh A Chiu; Ivan Rusyn
Journal:  Toxicology       Date:  2018-07-24       Impact factor: 4.221

4.  Comparative analysis of the relationship between trichloroethylene metabolism and tissue-specific toxicity among inbred mouse strains: kidney effects.

Authors:  Hong Sik Yoo; Blair U Bradford; Oksana Kosyk; Takeki Uehara; Svitlana Shymonyak; Leonard B Collins; Wanda M Bodnar; Louise M Ball; Avram Gold; Ivan Rusyn
Journal:  J Toxicol Environ Health A       Date:  2015

Review 5.  Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence.

Authors:  Edward A Lock; Jing Zhang; Harvey Checkoway
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-07       Impact factor: 4.219

Review 6.  Trichloroethylene: Mechanistic, epidemiologic and other supporting evidence of carcinogenic hazard.

Authors:  Ivan Rusyn; Weihsueh A Chiu; Lawrence H Lash; Hans Kromhout; Johnni Hansen; Kathryn Z Guyton
Journal:  Pharmacol Ther       Date:  2013-08-23       Impact factor: 12.310

Review 7.  Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis.

Authors:  Jane C Caldwell; Nagalakshmi Keshava
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

8.  Intravenous Single-Dose Toxicity of Redaporfin-Based Photodynamic Therapy in Rodents.

Authors:  Luis B Rocha; Fábio Schaberle; Janusz M Dąbrowski; Sérgio Simões; Luis G Arnaut
Journal:  Int J Mol Sci       Date:  2015-12-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.